Southern California Research Center for ALPD and Cirrhosis
南加州 ALPD 和肝硬化研究中心
基本信息
- 批准号:9112542
- 负责人:
- 金额:$ 1.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2015-12-31
- 项目状态:已结题
- 来源:
- 关键词:Alcohol abuseAlcoholic Liver DiseasesAlcoholsAnimal ModelAnimalsCaliforniaCell SeparationCellsCholecystokininCirrhosisCollaborationsCommunitiesDevelopmentDiseaseDisease modelEducationEducation and OutreachEducational process of instructingEnvironmentEthanolExhibitsFacultyFosteringFunctional disorderFundingFuture GenerationsGenerationsGoalsGrantHealth PersonnelHepatic Stellate CellHepatitis C virusHepatocyteHome environmentHybridsInfusion proceduresInstitutionInternationalLife StyleLiverLiver FibrosisMediatingMedicalMissionModelingMolecularMonoclonal Antibody R24Morbidity - disease rateNational Institute on Alcohol Abuse and AlcoholismNuclear Pore ComplexOncogenicOutcomePancreasPancreatic DiseasesPathologicPathologyPatientsPositioning AttributePostdoctoral FellowPredispositionPreparationPreventivePrincipal InvestigatorProgram Research Project GrantsPublic HealthPublicationsResearchResearch InfrastructureResearch PersonnelResearch TrainingResolutionResourcesRodentRodent ModelRoleSamplingScienceScientistSeminalStagingTLR4 geneTechnologyTherapeuticTimeTissuesTrainingTraining and EducationTransgenic MiceTrypsinogenUnited States National Institutes of Healthacute pancreatitisalcohol researchbasecareer developmentcell typeclinically relevantcollaborative environmentfeedinggenetic approachgraduate studentin vivoinnovationinsightmembermortalitymouse modelnoveloutreachproblem drinkerprogramspublic health relevancesymposiumtumortumorigenesisundergraduate studentwestern diet
项目摘要
DESCRIPTION (provided by applicant): Alcoholic liver and pancreatic diseases (ALPD) and cirrhosis constitute leading life-style diseases around the globe. The Southern California Research Center for ALPD and Cirrhosis unifies 57 investigators from major academic institutions in Southern California to pursue a common mission of being a leader in research, training, and outreach for the diseases. The center, since its inception in 1999, has devoted its efforts for development and use of clinically relevant animal models to gain novel insights into the molecular mechanisms underlying the predisposition to advanced ALPD. These efforts culminated to recent groundbreaking discoveries which have significantly advanced our understanding of synergistic ALPD caused by alcohol and a second hit. The center's interactive environment and infrastructure have facilitated in the past 5 years, a 152% increase in research base to $8.5M/year; 4 new UOl/POI programs; 198 publications; generation of 14 NIH-funded early-stage investigators; transition of 8 postdocs to faculty positions; training 166 graduate and
20 undergraduate students; and organizing 3 community seminars and 4 international symposia. As a unique national resource, the center has provided to scientific communities across the nation: 229 rodents as ALPD models and 241 model samples for 17 outside investigators; 329 liver cell isolation preparations for 14 investigators; and support for grant acquisition and application by 12 outside investigators since the last renewal. The center will continue to strive as a unique scientific center of excellence in ALPD and cirrhosis by promoting: 1) environment conducive for leading-edge research on the center's theme: elucidation of the priming and sensitizing mechanisms for ALPD; 2) provision of unique models, innovative genetic approaches and expertise to outside investigators including those at other NIAAA Alcohol Research Centers; 3) comprehensive education and training to foster future generations of scientists in ALPD and cirrhosis; and 4) outreach efforts to disseminate the center's new findings to lay public, health care workers and scientists in our home and global communities.
描述(由申请人提供):酒精性肝脏和胰腺疾病(ALPD)和肝硬化构成了全球领先的生活方式疾病。南加州ALPD和Cirrhosis研究中心统一了来自南加州主要学术机构的57名调查人员,以追求成为疾病研究,培训和外展领导者的共同使命。自1999年成立以来,该中心一直致力于开发和使用临床相关的动物模型,以获取对倾向倾向的高级ALPD的分子机制的新见解。这些努力最终达到了最近的开创性发现,这些发现极大地提高了我们对酒精引起的协同ALPD的理解和第二次打击。在过去的5年中,该中心的互动环境和基础设施促进了研究基础152%,至850万美元; 4个新的UOL/POI程序; 198出版物; 14个由NIH资助的早期研究人员产生;过渡了8个博士后到教师职位;培训166毕业生
20名本科生;并组织3个社区研讨会和4场国际研讨会。作为一个独特的国家资源,该中心已为全国各地的科学社区提供:229种啮齿动物作为ALPD型号,并为17名外部研究人员提供241个模型样本; 14名研究人员的329个肝细胞分离制剂;自上次续签以来,12名外部调查人员的赠款获得和申请支持。 该中心将通过促进:1)有利于对该中心主题的领先研究的环境来继续作为ALPD和Cirrhosis的独特科学科学中心:阐明ALPD的启动和敏感机制; 2)提供独特的模型,创新的遗传方法和专业知识,包括其他NIAAA酒精研究中心的研究者; 3)全面的教育和培训,以培养ALPD和肝硬化的后代科学家; 4)宣传努力,以传播该中心的新发现,以在我们的家庭和全球社区中为公众,卫生保健工作者和科学家奠定。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HIDEKAZU TSUKAMOTO其他文献
HIDEKAZU TSUKAMOTO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HIDEKAZU TSUKAMOTO', 18)}}的其他基金
Molecular Mechanisms of Stellate Cell Activation in Liver Fibrosis
肝纤维化星状细胞激活的分子机制
- 批准号:
9559537 - 财政年份:2013
- 资助金额:
$ 1.5万 - 项目类别:
Molecular Mechanisms of Stellate Cell Activation in Liver Fibrosis
肝纤维化星状细胞激活的分子机制
- 批准号:
9275383 - 财政年份:2013
- 资助金额:
$ 1.5万 - 项目类别:
Molecular Mechanisms of Stellate Cell Activation in Liver Fibrosis
肝纤维化星状细胞激活的分子机制
- 批准号:
10476009 - 财政年份:2013
- 资助金额:
$ 1.5万 - 项目类别:
The dynamics and mechanisms of autophagy in ethanol - induced liver pathogenesis
乙醇诱导的肝脏发病过程中自噬的动态和机制
- 批准号:
9112813 - 财政年份:2013
- 资助金额:
$ 1.5万 - 项目类别:
The dynamics and mechanisms of autophagy in ethanol - induced liver pathogenesis
乙醇诱导的肝脏发病过程中自噬的动态和机制
- 批准号:
8576712 - 财政年份:2013
- 资助金额:
$ 1.5万 - 项目类别:
The dynamics and mechanisms of autophagy in ethanol - induced liver pathogenesis
乙醇诱导的肝脏发病过程中自噬的动态和机制
- 批准号:
8891314 - 财政年份:2013
- 资助金额:
$ 1.5万 - 项目类别:
相似国自然基金
果糖通过m6A识别蛋白IGF2BP3促进非酒精性脂肪性肝病的作用和机制研究
- 批准号:82300961
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
从AMPK调控线粒体裂变和融合研究金钗石斛总生物碱抗非酒精性脂肪肝病的分子机制
- 批准号:82360808
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
植物性饮食及肠木质素与非酒精性脂肪性肝病人群肝纤维化发生风险的前瞻性研究
- 批准号:82373673
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于Keap1-Nrf2信号通路介导的抗氧化失衡探讨红芪多糖对非酒精性脂肪肝病铁死亡的干预效应及作用机制研究
- 批准号:82360914
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
大蒜素通过调控FGFR4-AMPK-Caspase 6信号通路对非酒精性脂肪肝病的改善作用及机制研究
- 批准号:82304128
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Phosphodiesterase 4B Inhibition as a Therapeutic Target for Alcohol-associated Liver Disease
磷酸二酯酶 4B 抑制作为酒精相关性肝病的治疗靶点
- 批准号:
10354185 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
Role of Lysosome Damage in ALD Pathogenesis
溶酶体损伤在 ALD 发病机制中的作用
- 批准号:
10668006 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
Aspartate beta-hydroxylase and DNA damage in chronic liver diseases
慢性肝病中的天冬氨酸 β-羟化酶和 DNA 损伤
- 批准号:
10667881 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
BEASTS-Novel Biomimetic Liver Platform for Enabling ALD Researchers
BEASTS-为 ALD 研究人员提供支持的新型仿生肝脏平台
- 批准号:
10697452 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
Cannabidiol as a treatment for alcoholic liver disease
大麻二酚治疗酒精性肝病
- 批准号:
10753729 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别: